There was no association between citrin mRNA expression and outcome of patients with lung adenocarcinoma (Figure 2I), and there was no association between expression levels of NAGS, CPS1, or citrin mRNA and outcome of patients with stomach adenocarcinoma (Figure 2J–L). Here, SLC25A13 is linked to gastric adenocarcinoma.